Glioblastoma: State-of-the-art therapeutic approaches
07 Jun 2022
byDr. Joyce Chow, Queen Elizabeth Hospital, Hong Kong; Dr. Tak-Lap Poon, Queen Elizabeth Hospital, Hong Kong
Glioblastoma multiforme (GBM) is a highly malignant cancer with a median overall survival (OS) of approximately 1 year. At a recent webinar, experts shared keys to effective management of GBM and discussed state-of-the-art therapeutic approaches, including tumour-treating fields (TTFields), fluorescence-guided surgery, as well as intraoperative ultrasound and neuro-navigation integration.